Current update of pediatric hepatitis vaccine use

Sheila Malay, Karen B. Tizer, Larry I. Lutwick

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Vaccines are now available for the prevention of hepatitis A and hepatitis B. In this article, biologics are reviewed with special attention to their use in the pediatric patient. Special attention is paid to issues that developed in 1999. For hepatitis A vaccine, it is the change in US recommendations regarding increased use in higher-risk US locations. For hepatitis B vaccine, it is the concern about toxicity, real or imagined.

Original languageEnglish (US)
Pages (from-to)395-406
Number of pages12
JournalPediatric Clinics of North America
Volume47
Issue number2
StatePublished - 2000
Externally publishedYes

Fingerprint

Hepatitis A Vaccines
Hepatitis B Vaccines
Hepatitis A
Biological Products
Hepatitis B
Hepatitis
Vaccines
Pediatrics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Current update of pediatric hepatitis vaccine use. / Malay, Sheila; Tizer, Karen B.; Lutwick, Larry I.

In: Pediatric Clinics of North America, Vol. 47, No. 2, 2000, p. 395-406.

Research output: Contribution to journalArticle

Malay, S, Tizer, KB & Lutwick, LI 2000, 'Current update of pediatric hepatitis vaccine use', Pediatric Clinics of North America, vol. 47, no. 2, pp. 395-406.
Malay, Sheila ; Tizer, Karen B. ; Lutwick, Larry I. / Current update of pediatric hepatitis vaccine use. In: Pediatric Clinics of North America. 2000 ; Vol. 47, No. 2. pp. 395-406.
@article{adaa4b7ccf8b47d5a0cb709d3cd083ff,
title = "Current update of pediatric hepatitis vaccine use",
abstract = "Vaccines are now available for the prevention of hepatitis A and hepatitis B. In this article, biologics are reviewed with special attention to their use in the pediatric patient. Special attention is paid to issues that developed in 1999. For hepatitis A vaccine, it is the change in US recommendations regarding increased use in higher-risk US locations. For hepatitis B vaccine, it is the concern about toxicity, real or imagined.",
author = "Sheila Malay and Tizer, {Karen B.} and Lutwick, {Larry I.}",
year = "2000",
language = "English (US)",
volume = "47",
pages = "395--406",
journal = "Pediatric Clinics of North America",
issn = "0031-3955",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Current update of pediatric hepatitis vaccine use

AU - Malay, Sheila

AU - Tizer, Karen B.

AU - Lutwick, Larry I.

PY - 2000

Y1 - 2000

N2 - Vaccines are now available for the prevention of hepatitis A and hepatitis B. In this article, biologics are reviewed with special attention to their use in the pediatric patient. Special attention is paid to issues that developed in 1999. For hepatitis A vaccine, it is the change in US recommendations regarding increased use in higher-risk US locations. For hepatitis B vaccine, it is the concern about toxicity, real or imagined.

AB - Vaccines are now available for the prevention of hepatitis A and hepatitis B. In this article, biologics are reviewed with special attention to their use in the pediatric patient. Special attention is paid to issues that developed in 1999. For hepatitis A vaccine, it is the change in US recommendations regarding increased use in higher-risk US locations. For hepatitis B vaccine, it is the concern about toxicity, real or imagined.

UR - http://www.scopus.com/inward/record.url?scp=0034115614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034115614&partnerID=8YFLogxK

M3 - Article

C2 - 10761510

AN - SCOPUS:0034115614

VL - 47

SP - 395

EP - 406

JO - Pediatric Clinics of North America

JF - Pediatric Clinics of North America

SN - 0031-3955

IS - 2

ER -